InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,792.80
(
0.00%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.25
(
-0.41%
)
Bitcoin
62,885.48
(
3.46%
)
Post# of 3647
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

johnnymcgriffin347

Send PM Follow Ignore
Followers 0
Posts 541
Boards Moderated 0
Alias Born 11/13/2018

johnnymcgriffin347

Re: None

Monday, 04/26/2021 11:34:29 PM

Monday, April 26, 2021 11:34:29 PM

Post# of 3647
Zhittya Genesis Medicine Lawsuit Against CardioVascular BioTherapeutics- victory for Zhittya Genesis Medicine confirmed by the US Federal Court

CVBT/Venturis Therapeutics' claim of IP theft was dismissed in total. Zhittya Genesis Medicine/Zhittya Regenerative Medicine was confirmed to own all of its IP without question. CVBT/VT's management's attempt to harm their competitor has backfired. Dan Montano, CEO of Zhittya Genesis Medicine/Zhittya Regenerative Medicine now has a judgement against CVBT/VT for $1 million dollars confirmed by the United States Federal Courts.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up